CRISPR Therapeutics
CRSP
#2932
Rank
$5.42 B
Marketcap
$56.88
Share price
-2.23%
Change (1 day)
14.89%
Change (1 year)

Financial Statements

Thumbnail CRISPR Therapeutics Financial Statement 2024

Financial Statement 2024

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2023

Financial Statement 2023

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2022

Financial Statement 2022

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2021

Financial Statement 2021

Language: English

View Financial Statement